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Background: There are limited data on healthcare-associated infections (HAI) from Afri-
can countries like Malawi.
Aim: We undertook a point prevalence survey of HAI and antimicrobial use in the surgery
department of Queen Elizabeth Central Hospital (QECH) in Malawi and ascertained the
associated risk factors for HAI.
Methods: A cross-sectional point prevalence survey (PPS) was carried out in the surgery
department of QECH. The European Centre for Disease Prevention and Control PPS pro-
tocol version 5.3 was adapted to our setting and used as a data collection tool.
Findings: 105 patients were included in the analysis; median age was 34 (IQR: 24e47)
years and 55.2% patients were male. Point prevalence of HAI was 11.4% (n¼12/105) (95%
CI: 6.0%e19.1%), including four surgical site infections, four urinary tract infections, three
bloodstream infections and one bone/joint infection. We identified the following risk
factors for HAI; length-of-stay between 8 and 14 days (OR¼14.4, 95% CI: 1.65e124.7,
p¼0.0143), presence of indwelling urinary catheter (OR¼8.3, 95% CI: 2.24e30.70,
p¼0.003) and history of surgery in the past 30 days (OR¼5.11, 95% CI: 1.46e17.83,
p¼0.011). 29/105 patients (27.6%) were prescribed antimicrobials, most commonly the
3rd-generation cephalosporin, ceftriaxone (n¼15).
Conclusion: The prevalence rates of HAI and antimicrobial use in surgery wards at QECH
are relatively high. Hospital infection prevention and control measures need to be
strengthened to reduce the burden of HAI at QECH.
ª 2021 The Authors. Published by Elsevier Ltd
on behalf of The Healthcare Infection Society. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Bunduki).
Elsevier Ltd on behalf of The Healthcare Infection Society. This is an open access article
ivecommons.org/licenses/by-nc-nd/4.0/).
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Healthcare-associated infections (HAI) constitute a world-
wide public health concern affecting hospitalised patients,
hospitals and health systems [1e3]. They increase healthcare
costs by prolonging the hospital stay and requiring the use of
expensive broad-spectrum antibiotics and they are associated
with high morbidity and mortality [4e7].
Increasing antimicrobial resistance (AMR) is associated with
antimicrobial consumption, suggesting that optimising anti-
microbial prescription may curb the development of AMR [5,8].
The use of broad-spectrum antibiotics in the treatment of HAI
before the results of culture may drive the emergence and
spread of multidrug-resistant (MDR) pathogens in hospital set-
tings and their dissemination to the community. However, in a
context where the microbiology service is limited, HAI are
diagnosed clinically and treated empirically. This makes the
treatment of HAI less effective and more costly [4,5,9]. In
Europe, about 1%e35% of pathogens isolated in HAI are resist-
ant to antimicrobials [10e14]. Meanwhile, the AMR rates
reported among isolates from HAI in Africa are of 10%e100%
[4,15].
Data on HAI from low and middle income countries (LMICs),
like Malawi, are limited, posing challenges on assessing the
impact of control interventions and surveillance strategies
[1,5,9,16]. Where studied, prevalence of HAI in Africa has been
reported in up to 15.5% of patients admitted to general wards
and 50% of patients admitted to intensive care units (ICUs)
[1,9,16,17]. High rates of HAI in Africa are due to the paucity of
infection prevention and control (IPC) policies and guidelines,
exacerbated by the lack of personnel, lack of antimicrobial
policies resulting in the emergence of MDR pathogens, poor
laboratory support, limited funding, and suboptimal adherence
to safe practices by health workers and typically limited
compulsion to report HAI [4,9,15,18,19]. In addition to these,
the structure of hospitals (including the fixed components
within the facility with which health care workers, patients,
and families touch or interact as a part of the health care
process) plays a role in risk of acquiring HAI [20].
It has been estimated that evidence-based interventions
can prevent about 50% of HAI [1], and clinical and micro-
biological surveillance of HAI is a major component of assessing
strategies to reduce HAI within hospitals [18]. Moreover, these
data are useful in prioritizing further areas for interventions in
the prevention and control of HAI [4,18,21]. Whilst prospective
longitudinal clinical surveillance is optimal, it is resource-
intense. Consequently, cross-sectional point prevalence sur-
veys (PPS) are pragmatic alternatives that can provide valuable
snapshots of the HAI burden and epidemiology as they can be
conducted quickly and without sophisticated techniques
[5,22e24]. In HAI PPS, the McCabe score is used as a subjective
score of underlying illness severity. It is an important tool for
risk stratification in infection prevention and control [25].
Currently, there is no HAI surveillance system in Malawi.
Therefore, this study aimed at estimating the point prevalence
of HAI and antimicrobial use in the surgery department of
Queen Elizabeth Central Hospital (QECH) in Malawi and ascer-
tained the associated risk factors for HAI.Methods
Study setting
The study was conducted at QECH, a large urban govern-
ment central hospital in Blantyre, which has a capacity of
about 1,300 beds but frequently operates above its capacity.
Its surgery department provides care in general surgery,
orthopaedics, neurosurgery, and paediatric surgery. The 4
surgical wards at QECH, with about 190 inpatient beds were
surveyed in this study. The accident and emergency wards and
ear, nose and throat department were excluded and wards
under the Mercy James Centre (MJC) for paediatric surgery and
intensive care were not included.Study design
A single-day cross-sectional point prevalence survey (PPS)
was conducted in different wards of the surgery department of
QECH on 9th June 2020, using an adapted version of the Euro-
pean Centre for Disease Prevention and Control (ECDC) tool for
PPS on HAI and antimicrobial use, protocol version 5.3 [26].Inclusion and exclusion criteria
Patients admitted to surgical wards before or at 8 a.m. on
the day of the survey and not discharged at the time of the
survey were included in the study. Patients who were trans-
ferred in/out after 8 a.m. from/to another unit were also
excluded. In addition, all day cases patients (patients under-
going same-day treatment or surgery, patients seen at the
outpatient department, patients in an emergency room and
dialysis patients) were excluded. Patients admitted in gynae-
cology and obstetrics department were excluded. All patients
hospitalised for less than 48 hours were also excluded in the
study.Data collection
Data were collected by a clinical microbiologist, and by
nurses trained in use of the data collection tool and the case
report form. Before data collection, a competency-based
evaluation was undertaken. For all eligible patients with or
without a HAI, a case report form was used for collecting
demographic data, clinical history (length of hospital stay
(LOS), surgical procedure, indwelling devices, comorbidities),
information on antimicrobial use, data on HAI if present,
results of routine microbiological tests performed if available,
and calculating the McCabe score. The McCabe score catego-
rizes the severity of underlying medical conditions into non-
fatal disease (expected survival of at least five years), ulti-
mately fatal disease (expected survival between one and five
years), rapidly fatal disease (expected death within one year)
and unknown [26].
Figure 2. Distribution of different hospital-acquired infections
among admitted patients in surgical wards at QECH (N¼12).
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The ECDC criteria and definitions for HAI [26] were used and
these are based on the presence of signs and symptoms of a
particular HAI on the day of the survey, with or without
microbiological results. Briefly, an infection was considered to
be HAI when the onset of the signs and symptoms occurred >48
hours after the current admission or became apparent within
48 hours of admission, but the patient had been discharged
from an acute care hospital <48 hours before the current
admission [26]. Infections were categorized into surgical site
infection, bone/joint infection, urinary tract infection, sepsis
or bloodstream infection, pneumonia, and other infections
including skin and soft tissue infection, nervous system infec-
tions, and gastrointestinal tract infection [5,26]. For surgical
site infections (SSIs), the definition included infections that
occurred up to 30 days after a surgical procedure and affected
either the incision or deep tissue at the surgical site, or
infections related to an implant that occurred within one year.
Moreover, device-associated HAI was recorded for urinary tract
infections (urinary catheter in place within seven days pre-
ceding HAI onset), sepsis or bloodstream infections (vascular
catheter in place within 48 hours before HAI onset) and pneu-
monia (intubation within 48 hours before HAI onset) [26].Figure 1. Flow chart of patients’ recruitment.Data analysis
Data were entered into MS Excel 2010, double-checked for
coding errors, cleaned and exported into SPSS version 24 (IBM
Corp., Armonk, NY, USA) and Stata 16 (StataCorp., USA) for
analysis. The point prevalence of HAI was reported as per-
centage of the patients with at least one clinically identified
HAI divided by the total number of included patients. Preva-
lence rates were calculated with the exact binomial 95% con-
fidence intervals (95% CI). Arithmetic means, median and
interquartile range (IQR) were calculated to summarise con-
tinuously measured variables. Effect sizes of associations of
risk factors with the outcome of HAI were reported using odds
ratios (ORs). For categorical and binary variables, Fisher’s
exact test was used to test the null hypothesis of no association
with HAI. Statistical significance was determined by p-values
<0.05. Due to the small number of HAI in our data, multi-
variable regression model of most variables was not reported as
this would have likely overfit and resulted in overinterpretation
of the results and unstable coefficient estimates. However, for
avoiding loss of information in categorising the continuous
variable LOS, we fit a logistic regression model for HAI against
LOS using restricted cubic splines (RCS), using R v4.0.2 [27] and
the rms package v6.0.0. [28]. We used Akaike’s Information
Criterion (AIC) to select the number of knots, with a model with
3 knots having the lowest AIC and having therefore been
selected. To test the null hypothesis of no association between
HAI and LOS we performed a likelihood ratio test, comparing
the RCS model to an intercept-only model.Ethical considerations
The study was approved by the College of Medicine Research
and Ethics Committee (COMREC), protocol number P.10/19/
2834. Informed written consent was obtained from patients,
who were free to withdraw their consent at any time.
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A total of 113 patients were screened on the survey day
(Figure 1). The bed occupancy rate was 59.5%. Of the 113
screened patients, 105 were hospitalised for >48 hours and
were hence included in the study. Eight of the 113 screened
patients were excluded because they were admitted after 8:00
a.m. on the day of the survey (2), and/or with a hospital stay
<48 hours (5), and/or found in a ward but already discharged
(1). Of the 105 included patients, 12 (11.4%) (95% CI: 6.0%e
19.1%) had HAI and 29 (27.6%) (95% CI: 19.3%e37.2%) were
prescribed at least one antimicrobial drug. The most fre-
quently reported HAI were surgical site infections (n¼4, 33.3%)
and urinary tract infections (n¼4, 33.3%), followed by blood-
stream infections (n¼3, 25.0%) and bone/joint infections (n¼1,
8.3%) (Figure 2). Of the 12 HAI identified, six (50.0%) wereTable I





Patients’ characteristics, n (%)
Gender
Female 47 (44.8) 41 (44.1)
Male 58 (55.2) 52 (55.9)
Age (years), Median (IQR) 34 (24e47)
<20 20 (19.0) 17 (18.3)
20e39 47 (44.8) 40 (43.0)
40e59 25 (23.8) 23 (24.7)
60 13 (12.4) 13 (14.0)
McCabe score**
Non-fatal diseases 77 (73.3) 68 (73.1)
Ultimately fatal disease 16 (15.3) 16 (17.2)
Rapidly fatal disease 4 (3.8) 4 (4.3)
Unknown 8 (7.6) 5 (5.4)
Exposure, n (%)
Length of stay (days), Median
(IQR)
8 (5e20)
7 42 (40.0) 41 (44.1)
8e14 27 (25.7) 20 (21.5)
15e21 12 (11.4) 10 (10.8)
22 24 (22.9) 22 (23.6)
Peripheral venous catheter
No 73 (69.5) 65 (69.9)
Yes 32 (30.5) 28 (30.1)
Indwelling urinary catheter
No 89 (84.8) 83 (89.2)
Yes 16 (15.2) 10 (10.8)
Documented comorbidities
No 63 (60.0) 57 (61.3)
Yes 42 (40.0) 36 (38.7)
Surgery in past 30 days
No 78 (74.3) 73 (78.5)
Yes 27 (25.7) 20 (21.5)
Patients on AM
Yes 29 (27.6) 18 (19.4)
No 76 (72.4) 75 (80.6)
HAI: healthcare-associated infections, IQR: interquartile range, AM: antim
**After removing the unknown category in the McCabe score, the p-value i
* P-values obtained using Fisher’s exact test.device-associated HAI (four urinary tract infections and two
bloodstream infections).Patients’ characteristics and risk factors for HAI
Of the 105 patients included in the survey, 58 (55.2%) were
male and 47 (44.8%) were female (Table I). The median age of
the patients was 34 (IQR: 24e47) years. 77 (73.3%) patients had
non-fatal diseases in the McCabe scoring. The median hospital
length of stay (LOS) was eight (IQR: 5e20) days. Of the patients
surveyed, 32 (30.5%) had a peripheral venous catheter, 16
(15.2%) had an indwelling urinary catheter, 42 (40.0%) had
documented comorbidities, and 27 (25.7%) had undergone
surgery in the past 30 days.
The following risk factors were significantly associated with
HAI: presence of indwelling urinary catheter (OR¼8.3, 95% CI:nts
Patients with HAI,
N¼12





6 (50.0) Ref. 16 (55.2)
6 (50.0) 0.79 (0.20e3.20) 13 (44.8)
0.4901
3 (25.0) Ref. 5 (17.2)
7 (58.3) 29.8 (6.46e201.4) 16 (55.2)
2 (16.7) 0.50 (0.038e4.88) 6 (20.7)
0 (0.0) 0.0 (0.0e3.68) 2 (6.9)
0.0731*
9 (75.0) Ref. 23 (79.3)
0 (0.0) 0.0 (0.0e2.43) 2 (6.9)
0 (0.0) 0.0 (0.0e13.10) 0 (0.0)
3 (25.0) 4.53 (0.59e27.65) 4 (13.8)
0.0143
1 (8.3) Ref. 11 (37.9)
7 (58.3) 14.4 (1.65e124.7) 11 (37.9)
2 (16.7) 8.20 (0.67e99.70) 4 (13.8)
2 (16.7) 3.73 (0.32e43.44) 3 (10.4)
1.000
8 (66.7) Ref. 10 (34.5)
4 (33.3) 0.86 (0.21e4.24) 19 (65.5)
0.003
6 (50.0) Ref. 20 (69.0)
6 (50.0) 8.30 (2.24e30.70) 9 (31.0)
0.537
6 (50.0) Ref. 19 (65.5)
6 (50.0) 1.58 (0.47e5.29) 10 (34.5)
0.011
5 (41.7) Ref. 14 (48.3)
7 (58.3) 5.11 (1.46e17.83) 15 (51.7)
11 (91.7) - - -
1 (8.3) - - -
icrobial agent.
s 0.5625.
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(OR¼5.11, 95% CI: 1.46e17.83, p¼0.011) and LOS between 8-14
days as associated risk with an OR¼14.4 (95% CI: 1.65e124.7,
p¼0.0143) (Table I). Given the non-linear association between
the probability of an HAI and LOS, we have repeated this last
analysis using a logistic regression model with restricted cubic
spline terms [29,30] for LOS and assessing the association
between HAI and LOS using a likelihood ratio test. This con-
firmed our finding (p¼0.0035 with this model).Antimicrobial use
Of the 29 patients that received antimicrobials, 13 (44.8%)
received one and 16 (55.2%) received two antimicrobial agents
(Table II). The purposes of prescribing antimicrobial agents
were for prophylaxis in three (10.3%) cases, therapeutic in 14
(48.3%) cases and both prophylaxis and therapeutic in 12
(41.4%) cases. The third-generation cephalosporin (ceftriax-
one) was used in 15 (51.7%) cases, metronidazole in 13 (44.8%)
cases, amoxicillin in seven (24.1%) cases, doxycycline in four
(13.8%) cases, ciprofloxacin in four (13.8%) cases and fluclox-
acillin in two (6.9%) cases.Table II










Number of AM prescribed
1 13 (44.8) 4 (30.8) 9 (69.2)
2 16 (55.2) 7 (43.8) 9 (56.2)
Purpose of AM use
Prophylactic 3 (10.3) 0 (0.0) 3 (100)
Therapeutic 14 (48.3) 4 (28.6) 10 (71.4)
Both 12 (41.4) 7 (58.3) 5 (41.7)
AM prescribed*
Ceftriaxone 15 (51.7) 7 (46.7) 8 (53.3)
Metronidazole 13 (44.8) 4 (30.8) 9 (69.2)
Amoxicillin 7 (24.1) 3 (42.9) 4 (57.1)
Doxycycline 4 (13.8) 2 (50.0) 2 (50.0)
Ciprofloxacin 4 (13.8) 2 (50.0) 2 (50.0)
Flucloxacillin 2 (6.9) 0 (0.0) 2 (100)
HAI: healthcare-associated infections, AM: antimicrobial agent.
* There are patients who received more than one antibiotic.
** Percentages of these columns are calculated by taking corre-
sponding lines of the first columns as the total.Discussion
In this single-day cross-sectional PPS, we observed an esti-
mated HAI point prevalence of 11.4%. This survey focused on
surgical wards in an urban teaching hospital in Malawi. Similar
studies reported HAI prevalence rates of 16.4% in Burkina Faso
[31], 14.3% in Nigeria [4] and 11.9% in Ethiopia [32].
The most frequent HAI were surgical site infections (SSI) and
urinary tract infections (UTI) (33.3% each), which is com-
parable to other settings [1,7,19]. Half of the reported infec-
tions were device-associated HAI, and thus preventable.
Prevention of HAI in surgical patients requires integrated IPC
measures before, during and after surgery [33,34]. This par-
ticularly applies while using medical devices, however, a pre-
vious study has reported a low adherence to hand hygiene
practice by clinicians and medical students at QECH [35]. A
recent report has proposed IPC among top priorities for
patient-centred surveillance of drug-resistant infections and
we echo this call [36].
The rate of antimicrobial prescribing (27.6%) found in this
survey is relatively higher than that reported in Iran (9.4%)
among patients with documented infections [22]. However,
Labi et al. reported 61% of patients on antibiotics in Ghana and
89.5% of them had HAI [2]. Our survey considered only the
surgery wards, while these other studies were conducted
within all the hospital wards and on a large scale including
several hospitals. The most frequently prescribed anti-
microbial was ceftriaxone. Since January 2020, QECH has rec-
ommended the use of cefazolin in surgical prophylaxis. The
exceptional use of ceftriaxone is only indicated for established
infection prior to surgery is done or in cases where patients
were already on ceftriaxone before the surgery, suggesting
much of this use was contrary to QECH guidelines, however this
study did not analyse the appropriateness of the use of anti-
biotics nor availability of cefazolin. A recent study from the
Democratic Republic of the Congo reported the use of cef-
triaxone in non-compliance with surgical antimicrobial pro-
phylaxis guidelines [37].In many sub-Saharan African healthcare facilities, third-
generation cephalosporins (3GCs) are the first choice for anti-
biotics used in the empiric treatment of acute and severe
infections [38]. In Malawi, lack of alternatives has been
reported as a reason for preventing the broad use of 3GCs in
most hospitals [39]. An antimicrobial stewardship program
implemented in adult medical wards at QECH was effective in
reducing the use of 3GCs [40]. Such a program should be
extended to other departments for promoting the rational use
of antibiotics as inappropriate use of 3GCs may facilitate the
emergence of multi-drug resistant pathogens. Certainly,
increased incidence of extended-spectrum beta-lactamase
(ESBL) producing Enterobacteriaceae has been reported since
the introduction of ceftriaxone into the Malawian formulary
[41].
We report hospital length of stay, presence of indwelling
urinary catheter and history of surgery in the past 30 days as
risk factors significantly associated with HAI, consistent with
other reports [2,9,22,24,42e45]. Indwelling urinary catheter
exposure is a well-established risk factor for UTI, associated
with extra hospital length of stay and healthcare-cost
[3,42,44,45]. Recent surgery may be a proxy for high-risk pro-
cedures such as central/peripheral vein catheter, urinary
catheter and endotracheal intubation during the surgical pro-
cedure. Placement of these invasive medical devices requires
strict hygiene measures because they are key risk factors for
HAI.
There were some limitations to our study; first, numbers
were small and the survey was not repeated. Second, as the
survey was conducted during the COVID-19 pandemic, infection
prevention and control (IPC) measures had recently been
reinforced in hospital, which might have influenced the HAI
prevalence. Further, the admission rate during this period was
decreased so nursing staff had fewer patients to care for.
Lastly, we could not assess the appropriateness of anti-
microbial use due to poor documentation of compliance
G.K. Bunduki et al. / Infection Prevention in Practice 3 (2021) 1001636measures, although this is typically a marker of poor practice in
antimicrobial prescribing.
Conclusions
To the best of our knowledge, this is the first survey
reporting on the epidemiology of HAI and antimicrobial use in
surgery wards in Malawi. The prevalence rates of HAI and
antimicrobial use in surgery units at QECH are relatively high
compared with other LMICs. Acquiring HAI was significantly
associated with length of stay, presence of indwelling urinary
catheter, and history of surgery in the past 30 days. Hospital
infection prevention and control measures should be
strengthened for reducing HAI burden at QECH. Interventions
supporting improved IPC should be implemented at QECH. In
addition, study on antimicrobial resistance patterns of bacteria
isolated from HAI should be conducted.
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